Literature DB >> 12730695

Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss.

Barmak Modrek1, Christopher J Lee.   

Abstract

One of the most interesting opportunities in comparative genomics is to compare not only genome sequences but additional phenomena, such as alternative splicing, using orthologous genes in different genomes to find similarities and differences between organisms. Recently, genomics studies have suggested that 40-60% of human genes are alternatively spliced and have catalogued up to 30,000 alternative splice relationships in human genes. Here we report an analysis of 9,434 orthologous genes in human and mouse, which indicates that alternative splicing is associated with a large increase in frequency of recent exon creation and/or loss. Whereas most exons in the mouse and human genomes are strongly conserved in both genomes, exons that are only included in alternative splice forms (as opposed to the constitutive or major transcript form) are mostly not conserved and thus are the product of recent exon creation or loss events. A similar comparison of orthologous exons in rat and human validates this pattern. Although this says nothing about the complex question of adaptive benefit, it does indicate that alternative splicing in these genomes has been associated with increased evolutionary change.

Entities:  

Mesh:

Year:  2003        PMID: 12730695     DOI: 10.1038/ng1159

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  234 in total

1.  Species-specific exon loss in human transcriptomes.

Authors:  Jinkai Wang; Zhi-xiang Lu; Collin J Tokheim; Sara E Miller; Yi Xing
Journal:  Mol Biol Evol       Date:  2014-11-14       Impact factor: 16.240

2.  Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.

Authors:  Tao Xie; Lee Rowen; Begoña Aguado; Mary Ellen Ahearn; Anup Madan; Shizhen Qin; R Duncan Campbell; Leroy Hood
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

3.  A non-EST-based method for exon-skipping prediction.

Authors:  Rotem Sorek; Ronen Shemesh; Yuval Cohen; Ortal Basechess; Gil Ast; Ron Shamir
Journal:  Genome Res       Date:  2004-08       Impact factor: 9.043

Review 4.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

5.  Accurate identification of novel human genes through simultaneous gene prediction in human, mouse, and rat.

Authors:  Colin Dewey; Jia Qian Wu; Simon Cawley; Marina Alexandersson; Richard Gibbs; Lior Pachter
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

6.  Evidence for a subpopulation of conserved alternative splicing events under selection pressure for protein reading frame preservation.

Authors:  Alissa Resch; Yi Xing; Alexander Alekseyenko; Barmak Modrek; Christopher Lee
Journal:  Nucleic Acids Res       Date:  2004-02-24       Impact factor: 16.971

7.  Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.

Authors:  Min Yang; Jack Wu; Si-Hung Wu; An-Ding Bi; D Joshua Liao
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

8.  Functional implications of the emergence of alternative splicing in hnRNP A/B transcripts.

Authors:  Siew Ping Han; Karin S Kassahn; Adam Skarshewski; Mark A Ragan; Joseph A Rothnagel; Ross Smith
Journal:  RNA       Date:  2010-07-22       Impact factor: 4.942

Review 9.  Alternative splicing and evolution: diversification, exon definition and function.

Authors:  Hadas Keren; Galit Lev-Maor; Gil Ast
Journal:  Nat Rev Genet       Date:  2010-04-08       Impact factor: 53.242

10.  A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Authors:  Auinash Kalsotra; Xinshu Xiao; Amanda J Ward; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.